Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study
- 1 January 1983
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 1 (2) , 145-147
- https://doi.org/10.1007/bf00182960
Abstract
Thirty-one evaluable adults with recurrent astrocytomas were treated with Cisplatin 35 Mg/ M2 I.V. daily for three days every 3–4 weeks. All patients had previously been irradiated and most had previously received chemotherapy. Approximately half had poor performance status. Two patients experienced complete remissions and two additional patients experienced partial remissions. Three patients stabilized. Gastrointestinal toxicity was generally mild. Further studies are planned of Cisplatin in combination with other agents.Keywords
This publication has 7 references indexed in Scilit:
- Weekly Cisplatin during cranial irradiation for malignant melanoma metastatic to brainJournal of Neuro-Oncology, 1983
- Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II).1983
- Human tissue distribution of platinum after cis-diamminedichloroplatinumCancer Chemotherapy and Pharmacology, 1982
- A PHASE-I STUDY OF INTRA-CAROTID ARTERY INFUSION OF CIS-DIAMMINEDICHLOROPLATINUM(II) IN PATIENTS WITH RECURRENT MALIGNANT INTRA-CEREBRAL TUMORS1982
- HUMAN CENTRAL NERVOUS-SYSTEM DISTRIBUTION OF CIS-DIAMMINEDICHLOROPLATINUM AND USE AS A RADIOSENSITIZER IN MALIGNANT BRAIN-TUMORS1982
- Cis-diamminedichloroplatinum (II)Annals of Internal Medicine, 1977
- Action of Cis-dichlorodiammineplatinum(II) (NSC-119875) at ehe cellular level.1975